University of Louisville is fastracking a novel treatment for novel Corona virus:
In a blog post, U of L touted a technology based on a piece of synthetic DNA called an aptamer, which targets and binds with a human protein called nucleolin.
"Early tests show that this aptamer may stop viruses, including novel coronavirus, from 'hijacking' nucleolin to replicate inside the body," the post reads.
From the actual blog post:"Early tests show that this aptamer may stop viruses, including novel coronavirus, from 'hijacking' nucleolin to replicate inside the body," the post reads.
Palmer, director of UofL’s Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases (CPM), conducted proof-of-concept experiments showing the aptamer was effective against the virus at doses previous research has shown to be safe in patients.
Last edited:
